The global regenerative market is estimated to reach USD 67.6 billion by 2019, from USD 16.4 billion in 2014, growing at a CAGR of 23.2 %. Small molecules and biologics show immense potential in the market and are estimated to grow at a CAGR of 18.9%.Regenerative medicines have the ability to restore the lost functionality of tissues or organs, unlike conventional medicines which are palliative.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/219522 .
A wi Plus
